Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Acquires Arkis Biosciences Inc.
Adds Unique Solution to Integra’s Neurocritical Care Offering PLAINSBORO, N.J., July 29, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that it has acquired Arkis Biosciences Inc.
View HTML
Toggle Summary Integra LifeSciences Reports Second Quarter 2019 Financial Results
Reported revenues increased 4.8% to $383.6 million; organic revenues increased 6.6%  GAAP and adjusted earnings per diluted share were $0.34 and $0.73, respectively The Company reaffirms revenue guidance and updates EPS guidance PLAINSBORO, N.J., July 24, 2019 (GLOBE NEWSWIRE) -- Integra
View HTML
Toggle Summary Integra LifeSciences to Host Second Quarter 2019 Earnings Results Conference Call on July 24, 2019
PLAINSBORO, N.J., July 10, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2019 financial results on Wednesday, July 24, 2019, prior to market open.
View HTML
Toggle Summary Integra LifeSciences Announces Promotion of Glenn Coleman to Newly-Created Role of Chief Operating Officer and Appointment of Carrie Anderson as Chief Financial Officer
PLAINSBORO, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced the promotion of Glenn Coleman to the newly-created role of chief operating officer (COO) and appointed Carrie Anderson as chief
View HTML
Toggle Summary Integra LifeSciences to participate in the Jefferies Healthcare Conference and the Raymond James Life Sciences and MedTech Conference in June 2019
PLAINSBORO, N.J., May 23, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in June: On Wednesday, June 5, 2019 at 4:30 p.m.
View HTML
Toggle Summary Integra LifeSciences to participate in Bank of America Merrill Lynch 2019 Healthcare Conference in May 2019
PLAINSBORO, N.J., April 30, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in May: On Tuesday, May 14, 2019 at 4:20 p.m.
View HTML
Toggle Summary Integra LifeSciences Reports First Quarter 2019 Financial Results
Reported revenues amounted to $359.7 million; organic revenues increased 3.1%  GAAP and adjusted earnings per diluted share were $0.38 and $0.65, respectively The Company reaffirms reported and organic revenue guidance for the full-year 2019 PLAINSBORO, N.J., April 24, 2019 (GLOBE NEWSWIRE) --
View HTML
Toggle Summary Integra LifeSciences Introduces New Codman Specialty Surgical Products at AANS 2019
New innovations designed to help advance patient care PLAINSBORO, N.J., April 11, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, announced today that it will feature its latest innovations at the American Association
View HTML
Toggle Summary Integra LifeSciences to Host First Quarter 2019 Earnings Results Conference Call on April 24, 2019
PLAINSBORO, N.J., April 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2019 financial results on Wednesday, April 24, 2019, prior to market open.
View HTML
Toggle Summary Integra LifeSciences Announces the Approval of DuraGen® in Japan
PLAINSBORO, N.J. and TOKYO, March 14, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART ), a global leader in medical technology, announces the recent approval of DuraGen ® Dural Regeneration Matrix in Japan. DuraGen is the first and only non-autologous collagen
View HTML
Toggle Summary Integra LifeSciences to participate in Healthcare Conference in March 2019
PLAINSBORO, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in March: On Tuesday, March 19, 2019 at 8:00 a.m.
View HTML
Toggle Summary Integra LifeSciences Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides 2019 Financial Guidance
Fourth Quarter 2018 reported revenue increased 4.0% to $383.3 million; organic revenue increased 4.4% Fourth Quarter 2018 GAAP earnings per diluted share were $0.29; adjusted earnings per diluted share were $0.65 The Company provides financial guidance for 2019 including total revenue in the range
View HTML
Toggle Summary Integra LifeSciences Launches the Integra® Panta® 2 TTC Arthrodesis Nail System
PLAINSBORO, N.J., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the launch of the Integra® Panta® 2 TTC Arthrodesis Nail System for tibio-talo-calcaneal (TTC) fusion of the ankle due to severe
View HTML
Toggle Summary Integra LifeSciences to Host Fourth Quarter and Full-Year 2018 Earnings Results Conference Call on February 21, 2019
PLAINSBORO, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full-year 2018 financial results on Thursday, February 21, 2019, prior to market open.
View HTML
Toggle Summary Integra LifeSciences Launches Integra® Titan™ Reverse Shoulder System-S
PLAINSBORO, N.J. , Jan. 10, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq:IART), a leading global medical technology company, today announced the full market release of the Integra® Titan™ Reverse Shoulder System-S (RSS-S).  This launch includes a new glenoid baseplate
View HTML